Sort by
Refine Your Search
-
, annual reports, initial license applications (New Drug Application (NDA)/Marketing Authorization Application (MAA), etc.) and supplements/variations). Develop and maintain knowledge of International
-
products in the region. Responsibilities Develops and maintains a broad knowledge of medical, scientific, and technical information for therapeutic area and product portfolio, becoming a scientific influenza
-
participate in projects to improve efficiency and compliance. · Agency Review Understanding: Build knowledge of agency review principles to facilitate effective submissions and interactions with
-
care worldwide. Through a phased training model, the program emphasizes both foundational knowledge and leadership development to prepare fellows for a successful career in the pharmaceutical industry
-
Improvement Initiatives: Actively participate in projects to improve efficiency and compliance. Agency Review Understanding: Build knowledge of agency review principles to facilitate effective submissions and
-
on several factors, which may include your education, experience, location, knowledge and expertise, and skills as well as a pay comparison to similarly-situated employees already in the role. Salary ranges
-
- $83,935.00 With the pay range(s) shown above, the starting salary will depend on several factors, which may include your education, experience, location, knowledge and expertise, and skills as well as a pay
-
of emerging science, and support the strategic dissemination of data that advances patient care worldwide. Through a phased training model, the program emphasizes both foundational knowledge and leadership
-
of their choice, with options including Scientific Communications, Medical Information, Field Medical, or Medical Operations for the second year. Medical Affairs Fellowship Objectives: Develop in-depth knowledge
-
Communications, Medical Information, Field Medical, or Medical Operations for the second year. Medical Affairs Fellowship Objectives: · Develop in-depth knowledge of Intellia’s CRISPR gene editing technology